The dynamics of the Degenerative Disc Disease market is anticipated to change in the coming years owing to the improvement in the rise in healthcare spending across the world

December 03 17:58 2021
The dynamics of the Degenerative Disc Disease market is anticipated to change in the coming years owing to the improvement in the rise in healthcare spending across the world
Degenerative Disc Disease Market
The anticipated entry of novel therapies such as IDCT, Rexlemestrocel, and others will fuel the Degenerative Disc Disease market growth.

DelveInsight’s Degenerative Disc Disease market report thoroughly explains the Degenerative Disc Disease historical and forecasted epidemiology and the Degenerative Disc Disease market trends in the 7MM. 

Some of the Key Highlights from the Degenerative Disc Disease Market Report

  • According to Bruin et al. (2018), degenerative changes were discovered in 456/648 patients (70.4%).

  • According to data published on the International Society for Pediatric Neurosurgery (ISPN), DDD is more common than previously thought, with 26% of asymptomatic children 16 years old demonstrating disc degeneration on MRI.

  • The leading players in the Degenerative Disc Disease market include Mesoblast, Gruenthal, Stayble Therapeutics, DiscGenics, Kuros Biosciences, Ankasa Therapeutics, Biorestorative Therapies, AnGes, and others.

  • Key Degenerative Disc Disease therapies in the pipeline include Rexlemestrocel, STA363, IDCT, Fibrin-PTH (KUR-113), ART352-L, BRTX-100, AMG0103, and others.

  • Rexlemestrocel, also known as Rexlemestrocel-L or MPC-06-ID, is a lead product candidate in late-stage development by Mesoblast in collaboration with Gruenthal to treat chronic low back pain caused by disc degeneration (CLBP).

  • Fibrin-PTH (KUR-113) is Kuros Biosciences’ first investigational drug-biologic product candidate for spinal fusion.

Request for a sample to know more @ Degenerative Disc Disease Market Outlook

Degenerative Disc Disease: Overview

Degenerative Disc Disease is a common disorder characterised by progressive degeneration of the intervertebral discs, which causes them to become deformed and mechanically dysfunctional. It is a catch-all term for various structural changes in the spine, including disc height loss, disc bulges, hydration, and nerve impingement in the spine, among others.

Degenerative Disc Disease Epidemiology Segmentation

The Degenerative Disc Disease report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:

  • Chronic Low Back Pain Total Prevalent Cases

  • Degenerative Disc Disease Total Prevalent Cases

  • Degenerative Disc Disease Diagnosed Cases

  • Degenerative Disc Disease Age-Specific and Gender-Specific Cases 

  • Degenerative Disc Disease Severity-Specific Cases 

  • Degenerative Disc Disease Treated Cases

Degenerative Disc Disease Treatment Landscape

Degenerative Disc Disease treatments are either passive or active. To help control the DDD symptoms, a combination of treatments is usually used. Passive Degenerative Disc Disease treatments are rarely effective on their own; almost always, an active component, such as exercise, is required. Passive Degenerative Disc Disease treatments for low back pain caused by degenerative disc disease may include pain medication, epidural injections, artificial disc replacement, diskectomy, and spinal fusion.

Degenerative Disc Disease Market Outlook

The anticipated entry of novel therapies such as IDCT, Rexlemestrocel, and others will fuel the Degenerative Disc Disease market growth during the forecast period (2021-30), and advances in cell biology will also contribute to the development of novel therapeutics for Degenerative Disc Disease.

Get a detailed analysis of the market @ Degenerative Disc Disease Market Share

Degenerative Disc Disease Pipeline Therapies and Key Companies 

  • Rexlemestrocel: Mesoblast/ Gruenthal

  • STA363: Stayble Therapeutics

  • IDCT: DiscGenics

  • Fibrin-PTH (KUR-113): Kuros Biosciences

  • ART352-L: Ankasa Therapeutics

  • BRTX-100: Biorestorative Therapies

  • AMG0103: AnGes

Table of Contents 

1.

Key Insights

2.

Executive Summary of Degenerative Disk Disease (DDD)

3.

SWOT Analysis of Degenerative Disk Disease (DDD)

4.

Degenerative Disk Disease (DDD): Market Share (%) Distribution Overview at a Glance: By Country

5.

Degenerative Disk Disease Epidemiology and Market Methodology

6.

Degenerative Disk Disease (DDD): Disease Background and Overview

7.

Degenerative Disk Disease Epidemiology and Patient Population

8.

Degenerative Disk Disease Epidemiology Scenario: 7MM

9.

Degenerative Disk Disease The United States Epidemiology

10.

Degenerative Disk Disease EU-5 Epidemiology

11.

Degenerative Disk Disease Japan Epidemiology

12.

Degenerative Disk Disease Current Treatment Practices

13.

Degenerative Disk Disease Unmet Needs

14.

Patient Journey of Degenerative Disk Disease (DDD)

15.

Key Endpoints in Degenerative Disk Disease (DDD) Clinical Trials

16.

Degenerative Disk Disease Marketed Therapies

17.

Degenerative Disk Disease Emerging Therapies

18.

Conjoint Analysis of Degenerative Disk Disease (DDD)

19.

Degenerative Disk Disease (DDD): Eight Major Market Analysis

20.

Degenerative Disk Disease 7MM Market Size

21.

Degenerative Disk Disease The United States Market Size

22.

Degenerative Disk Disease EU-5 Market Size

23.

Degenerative Disk Disease Japan Market Size

24.

Market Access and Reimbursement of Degenerative Disk Disease (DDD) Therapies

25.

Degenerative Disk Disease Market Drivers

26.

Degenerative Disk Disease Market Barriers

27.

Appendix

28.

DelveInsight Capabilities

29.

Disclaimer

30.

About DelveInsight

Get in touch with our business executive for Healthcare Due Diligence Services

Related Reports

Lumbar Disc Disease Market

DelveInsight’s “Lumbar Disc Disease- Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Lumbar Disc Disease, historical and forecasted epidemiology as well as the Lumbar Disc Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/

  Categories: